Streetbeat News

MRES

Institute of Biomedical Research Corp

http://www.institutebmr.com/

CEO

Boris Olekhnovich

Employees

Open

0.01

Mkt cap

21M

Volume

320K

High

0.01

P/E Ratio

N/A

52-wk high

0.01

Low

0.01

Div yield

N/A

52-wk low

0.00

Dr. Esmarilda Dankaert has been appointed as the Chief Innovation Officer at M2Bio Sciences, a biotechnology company focused on health and wellness. M2Bio Sciences, operating under The Institute of Biomedical Research Corp. (OTC PINK:MRES), is known for its innovative solutions in nutrition, health, and sustainability.

Portfolio Pulse from

November 25, 2024 | 2:15 pm

AI is being used to enhance psychedelic treatments, with companies like Institute of Biomedical Research Corp. (MRES), Cognetivity Neurosciences Ltd. (CGNSF), and Red Light Holland (TRUFF) exploring various applications. AI algorithms are being used to research psychedelic compounds, study cognitive health, and develop 3D movement data for therapy.

Portfolio Pulse from Lara Goldstein

June 08, 2023 | 9:25 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.